A simple and sensitive method in using the ratios of cholesteryl ester molecular species as indexes of oxidative stress in plasma and lipoprotein fractions

Atherosclerosis

Volumn 146, Issue 2, 1999, Pages 221-235

  Lee, Diana M ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Antioxidants; CE ratios; Gas chromatography; LDL; Lipid peroxidation; Oxidative status; Polyunsaturated fatty acids

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CHOLESTEROL ESTER; LIPID; LIPOPROTEIN; POLYUNSATURATED FATTY ACID;

ARTICLE; DIET SUPPLEMENTATION; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LIPID PEROXIDATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; TECHNIQUE;

CHOLESTEROL ESTERS; CHROMATOGRAPHY, GAS; COPPER; FEMALE; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; OXIDATIVE STRESS; PLASMA; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRIGLYCERIDES; VITAMIN E;

EID: 0032845921     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00136-7     Document Type: Article

References (36)

1. Di Mascio P., Murphy M.E., Sies H. Antioxidant defense systems: the role of carotenoids, tocopherols, and thiols. Am. J. Clin. Nutr. 53:1991;194S-200S.
2. Sies H. Biochemistry of oxidative stress. Angew Chem. Int. Ed. Engl. 25:1986;1058-1071.
3. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. New Engl. J. Med. 320:1989;915-924.
4. Esterbauer H., Striegl G., Puhl H., Dieber-Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free. Rad. Res. Comms. 6:1989;67-75.
5. Jürgens G., Hoff H.F., Chisolm G.M.I.I.I., Esterbauer H. Modification of human serum low density lipoprotein by oxidation - characterization and pathophysiological implications. Chem. Phys. Lipids. 45:1987;315-336.
6. Turrens J.F., Freeman B.A., Levitt J.G., Crapo J.D. The effect of hyperoxia on superoxide production by lung submitochondrial particles. Arch. Biochem. Biophys. 217:1982;401-410.
7. Cathcart M.K., McNally A.K., Chisolm G.M. Lipoxygenase-mediated transformation of human low density lipoprotein to an oxidized and cytotoxic complex. J. Lipid. Res. 32:1991;63-70.
8. Henriksen T., Mahoney E.M., Steinberg D. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc. Natl. Acad. Sci. USA. 78:1981;6499-6503.
9. Morel D.W., DiCorleto P.E., Chisolm G.M. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arterioscleriosis. 4:1984;357-364.
10. Heinecke J.W., Balser L., Rosen H., Chait A. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J. Clin. Invest. 77:1986;757-761.
11. Reaven P., Parthasarathy S., Grasse B.J., Miller E., Steinberg D., Witztum J. Effects of oleate-rich and linoleate-rich diet on the susceptibility of low density lipoprotein to oxidative modification in midly hypercholesterolemic subjects. J. Clin. Invest. 91:1993;668-676.
12. Lee D.M. α-Phenyl N-tert-butylnitrone as antioxidant for low density lipoproteins. Methods Enzymol. 234:1994;513-523.
13. Lee D.M. Apolipoprotein B-48: problems related to quantification. Methods Enzymol. 263:1996;146-165.
14. Lee D.M., Downs D. A quick and large-scale density gradient subfractionation method for low density lipoproteins. J. Lipid Res. 23:1982;14-27.
15. Fong K.-L., McCay P.B., Poyer J.L., Keele B.B., Misra H. Evidence that peroxidation of lysosomal membranes is initiated by hydroxyl free radicals produced during flavin enzyme activity. J. Biol. Chem. 248:1973;7792-7797.
16. Lee D.M. Malondialdehyde formation in stored plasma. Biochem. Biophys. Res. Commun. 95:1980;1663-1672.
17. Lee D.M., Valente A.J., Kuo W.H., Maeda H. Properties of apolipoprotein B in urea and in aqueous buffers. The use of glutathione and nitrogen in its solubilization. Biochim. Biophys. Acta. 666:1981;133-146.
18. Kuksis A., Myher J.J., Marai L., Geher K. Determination of plasma lipid profiles by automated gas chromatography and computerized data analyses. J. Chromatogr. Sci. 13:1975;423-430.
19. Roeschlau P., Bernt E., Gruber W. Enzymatic determination of total cholesterol in serum. Z. Klin. Chem. Klin. Biochem. 12:1974;226-227.
20. McGoowan M.W., Artis J.D., Strandbergh D.R., Zack B. A peroxidase coupled method for the colorimetric determination of serum triglycerides. Clin. Chem. 29:1983;538-542.
21. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499-502.
22. 2 mimics cell-mediated oxidative modification. J. Lipid. Res. 29:1988;745-753.
23. Esterbauer H, Quehenberger O, Jürgens G. Oxidation of human low density lipoprotein with special attention to aldehydic lipid peroxidation products. In: Rice-Evans C, Halliwell B, editors. Free Radicals: Methodology and Concepts. London: Richelieu Press, 1988:243-268.
24. Lang J., Celotto C., Esterbauer H. Quantitative determination of the lipid peroxidation product 4-hydroxynonenal by high-performance liquid chromatography. Analyt. Biochem. 150:1985;369-378.
25. Esterbauer H., Striegl G., Puhl H., Oberreither S., Rotheneder M., El-Saadani M., Jürgens G. The role of vitamin E and carotenoids in preventing oxidation of low density lipoproteins in vitamin E biochemistry and health implications. Ann. NY Acad. Sci. 570:1989;254-267.
26. Mackness M.I., Arrol S., Abbott C., Durrington P.N. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis. 104:1993;129-135.
27. 2+ and lipoxygenase: an electron spin resonance study. Biochim. Biophys. Acta. 1035:1990;286-292.
28. Avogaro P., Bon G.B., Cazzolato G. Presence of a modified low density lipoprotein in humans. Arteriosclerosis. 8:1988;79-87.
29. Miyazawa T., Fujimoto K., Oikawa S.-I. Determination of lipid hydroperoxides in low density lipoprotein from human plasma using high performance liquid chromatography with chemiluminescence detection. Biomed. Chromatogr. 4:1990;131-134.
30. Krithaeides L., Jessup W., Gifford J., Dean R.T. A method for defining the stages of low-density lipoprotein oxidation by the separation of cholesterol- and cholesteryl ester-oxidation products using HPLC. Anal. Biochem. 213:1993;79-89.
31. Maxwell S.R.J., Wiklund O., Bondjers G. Measurement of antioxidant activity in lipoproteins using enhanced chemiluminescence. Atherosclerosis. 111:1994;79-89.
32. Finckh B., Kontush A., Commentz A., Hubner C., Burdelski M., Kohlschutter A. Monitoring of ubiquinol-10, ubiquinone-10, carotenoids, and tocopherols in neonatal plasma microsamples using high-performance liquid chromatography with coulometric electrochemical detection. Anal. Biochem. 232:1995;210.
33. Kontush A., Reich A., Baum K., Spranger T., Finckh B., Kohlschutter A., Beisiegel U. Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia. Atherosclerosis. 129:1997;119-126.
34. 2α-I: an index of lipid peroxidation in humans. Proc. Natl. Acad. Sci. USA. 95:1998;3449-3454.
35. Cross C.E., Halliwell B., .Borish E.T. et al. Oxygen radicals and human disease. Ann. Intern. Med. 107:1987;526-545.
36. Crawwford R.S., Kirk E.A., Rosenfeld M.E., LeBoeuf R.C., Chait A. Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 18:1998;1506-1513.